Galderma Group is a dermatology company that develops and provides products across three main segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. It serves patients, consumers, and healthcare professionals globally.
Subscribe to see Galderma Group’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Galderma Group is a pharmaceuticals company. Xcout tracks 4 named people at Galderma Group, including Flemming Ørnskov (Chief Executive Officer). Xcout recorded 600 job postings from Galderma Group in the last 90 days, naming tools such as Power BI, SAP, Tableau.
Xcout recorded 600 job postings from Galderma Group in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Galderma Group's hiring signals →
Based on 365 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 168 enterprise healthcare companies.
This describes a hiring pattern — how often Galderma Group’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
A few of Galderma Group's closest competitors — see the full list of competitors and alternatives →
Laboratoires IPRAD is a French pharmaceutical and healthcare company that develops and markets over-the-counter medicines, medical devices, and dietary supplements. It is particularly associated with women’s health, intimate care, fertility, pregnancy, and family-health products, serving consumers and healthcare professionals.
Johnson & Johnson researches, develops, and delivers pharmaceutical medicines and medical technology products. The company serves patients and healthcare professionals globally by addressing complex medical challenges across therapeutic areas such as oncology, immunology, neuroscience, cardiovascular health, orthopaedics, surgery, and vision.
Adamed Pharma S.A. is a pharmaceutical and biotechnology company that researches, develops, and manufactures prescription drugs, over-the-counter medicines, dietary supplements, dermocosmetics, and medical devices. It serves patients across multiple therapeutic areas globally, utilizing its own scientific research and patents.
The Klosterfrau Group is a German healthcare company that develops, produces, and distributes over-the-counter pharmaceuticals, consumer healthcare products, medical products, cosmetics, and contract manufacturing solutions. It serves consumers seeking health, wellness, and self-medication products across national and international markets.
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment is dedicated to vision care, encompassing surgical instruments, consumer eye health products, and ophthalmic pharmaceuticals. Salix specializes in delivering gastroenterology-specific products exclusively within the United States. The International Rx division markets Solta products, a range of branded and generic pharmaceuticals, OTC items, medical devices, and Bausch + Lomb offerings across diverse geographies including Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. Ortho Dermatologics focuses on dermatological products in the U.S., in addition to distributing Solta's medical aesthetic devices globally. Finally, the Diversified Products segment supplies pharmaceutical solutions for neurology and other therapeutic categories, as well as generic medications and dental products, all within the U.S. The company was formerly known as Valeant Pharmaceuticals International, Inc., officially changing its name to Bausch Health Companies Inc. in July 2018. Its corporate headquarters are located in Laval, Canada.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.